Original Research
Published on 28 Aug 2023
Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1237078
- 2,912 views
- 3 citations
Volumes
70 Publications
Volume 3 - 2023
Review
Published on 23 Aug 2023
Mitochondrial calcium signaling and redox homeostasis in cardiac health and disease
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1235188
- 2,104 views
- 1 citation
Editorial
Published on 28 Jul 2023
Editorial: Heart valve diseases: from molecular mechanisms to clinical implications
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1260912
- 1,254 views
Original Research
Published on 24 Jul 2023
Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1152550
- 2,423 views
Editorial
Published on 27 Jun 2023
Editorial: CAR T-cells: novel therapeutic approaches in the new era of cancer immunotherapy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1239013
- 1,333 views
- 2 citations
Editorial
Published on 26 Jun 2023
Editorial: Biomarkers to evaluate rare diseases
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1237089
- 1,342 views
Review
Published on 14 Jun 2023
Interactions between astrocytes and extracellular matrix structures contribute to neuroinflammation-associated epilepsy pathology
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1198021
- 3,990 views
- 1 citation
Mini Review
Published on 06 Jun 2023
Muscle-derived exosomes and exercise in cancer prevention
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1202190
- 2,877 views
- 4 citations
Original Research
Published on 01 Jun 2023
Energy-based generative models for target-specific drug discovery
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1160877
- 1,289 views
- 2 citations
Perspective
Published on 18 May 2023
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1120090
- 1,838 views
- 2 citations
Original Research
Published on 18 May 2023
Phase I-II study using DeltaRex-G, a tumor-targeted retrovector encoding a cyclin G1 inhibitor for metastatic carcinoma of breast
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1105680
- 1,282 views
- 1 citation
Original Research
Published on 20 Apr 2023
Biomechanical and biochemical assessment of YB-1 expression in A375 melanoma cell line: Exploratory study
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1050487
- 1,577 views
- 2 citations
Review
Published on 03 Apr 2023
Gene transfer and genome editing for familial hypercholesterolemia
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1140997
- 6,344 views
- 2 citations
Review
Published on 31 Mar 2023
Gene therapy and genome editing for type I glycogen storage diseases
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1167091
- 4,446 views
- 2 citations
Perspective
Published on 23 Mar 2023
Human brain organoid code of conduct
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1143298
- 2,714 views
- 6 citations
Review
Published on 28 Feb 2023
The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospective
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1125928
- 840 views